Angiogenesis signaling and the development of upper-limb morbidity following breast cancer treatment

What is it about?

The review summarises what is known about the role of angiogenesis in post-treatment upper-limb morbidity and introduces a new topic for further research using findings from research on non-cancer general shoulder conditions.

Featured Image

Why is it important?

This work can guide future research aimed at explaining the reported clinical variability noted in the development of upper-limb morbidity among breast cancer survivors. A good characterization of the factors that contribute to this variability may assist in the identification of individuals at risk and facilitate the integration of early interventions such as physical therapy.